REPORT ID 6902

Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2017

Publish Date
1-Nov-17
Pages
106
Format
Electronic (PDF)

In this report, the global Plasma Protease C1-inhibitor Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Plasma Protease C1-inhibitor Treatment for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Plasma Protease C1-inhibitor Treatment market competition by top manufacturers/players, with Plasma Protease C1-inhibitor Treatment sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Shire plc
    CSL Limited
    Sanquin
    Pharming Group N.V.
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    by Drug Class
        C1-inhibitors
        Kallikrein Inhibitor (Kalbitor)
        Selective Bradykinin B2 Receptor Antagonist (Firazyr)
    by Dosage Type
        Liquid/Injectable
        Lyophilized
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Independent Pharmacies and Outlets

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2017
1 Plasma Protease C1-inhibitor Treatment Market Overview
    1.1 Product Overview and Scope of Plasma Protease C1-inhibitor Treatment
    1.2 Classification of Plasma Protease C1-inhibitor Treatment by Product Category
        1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Plasma Protease C1-inhibitor Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 C1-inhibitors
        1.2.4 Kallikrein Inhibitor (Kalbitor)
        1.2.5 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
    1.3 Global Plasma Protease C1-inhibitor Treatment Market by Application/End Users
        1.3.1 Global Plasma Protease C1-inhibitor Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital Pharmacies
        1.3.3 Independent Pharmacies and Outlets
    1.4 Global Plasma Protease C1-inhibitor Treatment Market by Region
        1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
        1.4.3 China Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
        1.4.4 Europe Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
        1.4.5 Japan Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
        1.4.7 India Plasma Protease C1-inhibitor Treatment Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Plasma Protease C1-inhibitor Treatment (2012-2022)
        1.5.1 Global Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2022)
        1.5.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2022)

2 Global Plasma Protease C1-inhibitor Treatment Competition by Players/Suppliers, Type and Application
     2.1 Global Plasma Protease C1-inhibitor Treatment Market Competition by Players/Suppliers
        2.1.1 Global Plasma Protease C1-inhibitor Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Plasma Protease C1-inhibitor Treatment (Volume and Value) by Type
        2.2.1 Global Plasma Protease C1-inhibitor Treatment Sales and Market Share by Type (2012-2017)
        2.2.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Market Share by Type (2012-2017)
    2.3 Global Plasma Protease C1-inhibitor Treatment (Volume and Value) by Region
        2.3.1 Global Plasma Protease C1-inhibitor Treatment Sales and Market Share by Region (2012-2017)
        2.3.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Market Share by Region (2012-2017)
    2.4 Global Plasma Protease C1-inhibitor Treatment (Volume) by Application

3 United States Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    3.1 United States Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        3.1.1 United States Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        3.1.2 United States Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        3.1.3 United States Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    3.2 United States Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    3.3 United States Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    3.4 United States Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

4 China Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    4.1 China Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        4.1.1 China Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        4.1.2 China Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        4.1.3 China Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    4.2 China Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    4.3 China Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    4.4 China Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

5 Europe Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    5.1 Europe Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        5.1.1 Europe Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        5.1.2 Europe Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    5.2 Europe Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    5.3 Europe Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    5.4 Europe Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

6 Japan Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    6.1 Japan Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        6.1.1 Japan Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        6.1.2 Japan Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    6.2 Japan Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    6.3 Japan Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    6.4 Japan Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

7 Southeast Asia Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    7.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        7.1.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    7.2 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    7.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    7.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

8 India Plasma Protease C1-inhibitor Treatment (Volume, Value and Sales Price)
    8.1 India Plasma Protease C1-inhibitor Treatment Sales and Value (2012-2017)
        8.1.1 India Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2012-2017)
        8.1.2 India Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate (2012-2017)
        8.1.3 India Plasma Protease C1-inhibitor Treatment Sales Price Trend (2012-2017)
    8.2 India Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Players
    8.3 India Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Type
    8.4 India Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share by Application

9 Global Plasma Protease C1-inhibitor Treatment Players/Suppliers Profiles and Sales Data
    9.1 Shire plc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Shire plc Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 CSL Limited
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Sanquin
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Pharming Group N.V.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Plasma Protease C1-inhibitor Treatment Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    ...

10 Plasma Protease C1-inhibitor Treatment Maufacturing Cost Analysis
    10.1 Plasma Protease C1-inhibitor Treatment Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
    10.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Plasma Protease C1-inhibitor Treatment Market Forecast (2017-2022)
    14.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Plasma Protease C1-inhibitor Treatment Price and Trend Forecast (2017-2022)
    14.2 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Type (2017-2022)
       14.3.2 Global Plasma Protease C1-inhibitor Treatment Revenue Forecast by Type (2017-2022)
       14.3.3 Global Plasma Protease C1-inhibitor Treatment Price Forecast by Type (2017-2022)
    14.4 Global Plasma Protease C1-inhibitor Treatment Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer